Participants who were HCV PCR-positive underwent clinical review before treatment including; a physical examination for any signs and symptoms of advanced liver disease (ascites and stigmata of cirrhosis), medical history (mental health, TB symptoms, alcohol use, medication review), and the following blood tests to determine treatment eligibility: alanine aminotransferase (ALT), aspartate aminotransferase (AST), and full hemogram. The gene discussed is GPT; the disease is Cirrhosis.